TLC Presentations Content

Access all presentations

Click on each presentation title to open & download a PDF of the slides or click here to download a zip file of all PDF presentations:

Download All

Early-Stage NSCLC

Optimizing Use of Neoadjuvant Immunotherapy in NSCLC

Tina Cascone, MD, PhD (MD Anderson Cancer Center)

Can We Convert Unresectable to Resectable?

Brendon Stiles, MD (Montefiore Medical Center)

Current Role of Adjuvant Immunotherapy in NSCLC

Jessica Donington, MD, MSCR (University of Chicago Medicine)

Current Role of Adjuvant Targeted Therapy in NSCLC

Eric Nadler, MD, MPP (Texas Oncology)

Best Practices in Unresectable NSCLC

David Spigel, MD (Sarah Cannon Research Institute)

Immunotherapy for Advanced NSCLC

When is PD(L)1 Monotherapy Enough?

Shirish Gadgeel, MD (Henry Ford Health)

Advantages of Chemo-Immunotherapy for NSCLC

Melissa Johnson, MD (Sarah Cannon Research Institute)

The Evolving Role of Dual Checkpoint Inhibition

Hossein Borghaei, DO, MS (Fox Chase Cancer Center)

Overcoming IO Resistance in NSCLC

Sheena Bhalla, MD (UT Southwestern Medical Center)

SCLC and Mesothelioma

Predicting the Future of Limited Stage SCLC

Kristin Higgins, MD (Emory Winship Cancer Institute)

Best Practice for Extensive Stage SCLC

Lauren Byers, MD (MD Anderson Cancer Center)

Managing Relapse for Advanced SCLC

Ticiana Leal, MD (Emory Winship Cancer Institute)

Current Standards in Mesothelioma

Melina Marmarelis, MD, MSCE (University of Pennsylvania)

Digital Oncology

Telehealth and Oncology: Natural Fit or Arranged Marriage?

Jack West, MD (City of Hope)

Remote Tobacco Cessation

Randi Williams, PhD, MPH (Georgetown University)

Mathematical Oncology

Alexander Anderson, PhD (Moffitt Cancer Center)

The Future of Social Media and Oncology

Narjust Florez (Duma), MD (Dana-Farber Cancer Institute)

IDEOlogy's Sound Bites platform offers a convenient, non-promotional way to stay up-to-date through short video clips from distinguished thought leaders.

No app to download. No ads.

Just timely clinical trial updates sent directly to your text messages.

Targeted Therapy: EGFR, HER2

Biomarkers: What is NGS?

Christine Lovly, MD, PhD (Vanderbilt University)

First Line EGFR NSCLC: Is TKI enough?

Sandip Patel, MD (UC San Diego Health)

Emerging Strategies for EGFR Exon 20

Julia Rotow, MD (Dana-Farber Cancer Institute)

Overcoming EGFR TKI Resistance

Jonathan Riess, MD, MS (UC Davis Health)

Targeting HER2 in NSCLC

Estelamari Rodriguez, MD, MPH (University of Miami)

Refining EGFR Classification

John Heymach, MD, PhD (MD Anderson Cancer Center)

Targeted Therapy: Mutations: KRAS/BRAF/MET and ADCs

Treating KRAS Mutant NSCLC

Ferdinandos Skoulidis, MD, PhD (MD Anderson Cancer Center)

Best Practice for BRAF Mutant NSCLC

Ibiayi Dagogo-Jack, MD (Massachusetts General Hospital)

Current and Future Practice for METex14

Paul Paik, MD (Memorial Sloan Kettering Cancer Center)

Placing ADCs in the Treatment Algorithm

Joshua Reuss, MD (Georgetown University)

Targeted Therapy: Fusions

First Line Options for ALK and ROS1 NSCLC

Jason Porter, MD (West Cancer Center)

Understanding and Overcoming Resistance in ALK/ROS1 NSCLC

Jessica Lin, MD, (Massachusetts General Hospital)

Targeted Therapy for RET NSCLC

Edgardo Santos, MD, FACP (Genesis Care US)

NTRK and NRG1 in NSCLC

Yasir Elamin, MD (MD Anderson Cancer Center)

Refining Practice for the Coming Year

Intersection of Community and Academic Oncology

R. Steven Paulson, MD (Texas Oncology)

How to Incorporate Liquid Biopsy in Practice

Luis Raez, MD (Memorial Cancer Institute)

Health Care Policy for Today's Oncologist

Debra Patt, MD, PhD (Texas Oncology)

Download a zip folder with all PDF presentations:

Download All

TLC Conference Presentation Access

To access all 2023 TLC Conference presentation slides, please fill out this form

"*" indicates required fields

Name*

Email Address*

Mobile Phone*

Medical Designation*

Institution/Clinic*

Other - Institution/Clinic

Other - Industry

Sign me up for 2024 TLC Conference announcements

Sign me up for 2024 TLC Conference announcements

Subscribe to Sound Bites

Subscribe to Sound Bites

IDEOlogy's patented Sound Bites platform offers a convenient, unbiased way to stay up-to-date through 1-minute videos from distinguished thought leaders. Timely clinical trial updates are sent directly to the mobile number you entered above. You will receive a ‘welcome text’ and be able to customize your experience by selecting oncology topics of your interest. We won’t send spam or ads, and if you decide this just isn’t for you, you can opt-out at anytime.

Comments

This field is for validation purposes and should be left unchanged.